After over a decade with HIV, a Norwegian man received a surprise through a stem cell donation from his sibling. The gifted ...

Norwegian study reports HIV remission after stem cell transplant, offering rare insight into potential cure pathways for the ...

"We haven't quite made it to the promised land. We're getting close." ...

The FDA has approved Merck’s once-daily, two-drug regimen for adults with virologically suppressed HIV-1. The treatment combines 100 mg doravirine and 0.25 mg islatravir and is indicated for patients ...

For the first time since HIV was identified, early human trials are starting to show what long‑imagined “drug‑free control” of the virus might look like in practice. Instead of chasing a total ...

A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described ...

The 63-year-old "Oslo patient" is considered to be in remission from HIV ...

Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso, a combination ...

Over the past three decades there have been amazing advances in treating and preventing HIV. It's now a manageable infection. A person with HIV who takes HIV medicine consistently, before their immune ...

In July 2024, we published a story with the headline: "One of the 7 people cured of HIV tells his story. Can his cure work for others." This summer, at the International AIDS Society conference, came ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

By Christy Santhosh and Sriparna Roy April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's ...